SpectraWAVE, Inc.

📍 Bedford, United States👥 74 employees💰 Last funded 2024
Medical Equipment Manufacturing🌐 spectrawave.com
Website LinkedIn
SpectraWAVE, located in Bedford, Mass., is a privately held medical device company founded in 2017 to provide unrivaled optical and computational insights to improve the treatment and outcomes for patients with coronary artery disease (CAD). CAD, the buildup of plaque in the wall of the arteries that supply blood to the heart, affects 18.2 million adults age 20 and older. In CAD patients that undergo percutaneous stent placement, it is estimated that one in five patients experience adverse events within two years. SpectraWAVE’s state of the art HyperVue™ Imaging System combines next generation DeepOCT™ images and near infrared spectroscopy (NIRS) with workflows optimized for the cardiac catheterization lab. The HyperVue Imaging System is intended for the imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. The NIRS capability of the system is intended for the identification of patients and plaques at increased risk of major adverse cardiac events. For more information and complete indications for use, please visit www.spectrawave.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in SpectraWAVE, Inc.?
SpectraWAVE, Inc. has 1 investors on record on gritt.io.
When did SpectraWAVE, Inc. last raise funding?
The most recent investment in SpectraWAVE, Inc. recorded on gritt.io was in 2024.
What industry is SpectraWAVE, Inc. in?
SpectraWAVE, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is SpectraWAVE, Inc. based?
SpectraWAVE, Inc. is headquartered in Bedford, United States.